BioNTech SE (BNTX) Operating Expenses (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Operating Expenses data on file, last reported at -$784.6 million in Q4 2025.

• In Q4 2025, Operating Expenses fell 1.61% year-over-year to -$784.6 million; the TTM figure through Dec 2025 stood at -$3.0 billion (up 1.74% YoY), while the FY2025 annual figure was -$3.0 billion, up 0.57% from the prior year.
• Operating Expenses grew to -$784.6 million in Q4 2025, from -$802.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at -$299.7 million in Q2 2021 and bottomed at -$813.6 million in Q2 2024.
• A 5-year average of -$600.6 million and a median of -$653.9 million in 2022 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2021 — Operating Expenses slumped 131816999.25% — and 2025, when it grew 12.79%.
• Year by year, Operating Expenses stood at -$460.3 million in 2021, then sank by 39.56% to -$642.4 million in 2022, then retreated by 17.58% to -$755.4 million in 2023, then declined by 2.22% to -$772.2 million in 2024, then slipped by 1.61% to -$784.6 million in 2025.
• The last three Operating Expenses figures came in at -$784.6 million (Q4 2025), -$802.0 million (Q3 2025), and -$709.5 million (Q2 2025), per Business Quant data.

Peer Comparison